Sangamo Therapeutics, Inc.
|
-45.32 Million USD
|
191.309%
|
IDEAYA Biosciences, Inc.
|
-106.12 Million USD
|
138.998%
|
Eton Pharmaceuticals, Inc.
|
21.06 Million USD
|
-96.505%
|
Autolus Therapeutics plc
|
-4.86 Million USD
|
950.339%
|
Greenwich LifeSciences, Inc.
|
-3612.00 USD
|
1145891.805%
|
Enlivex Therapeutics Ltd.
|
-835 Thousand USD
|
5056.407%
|
Shattuck Labs, Inc.
|
-2.38 Million USD
|
1835.262%
|
LENZ Therapeutics, Inc.
|
-2.4 Million USD
|
1819.402%
|
CervoMed Inc.
|
-1.29 Million USD
|
3299.222%
|
Rocket Pharmaceuticals, Inc.
|
-7.09 Million USD
|
683.066%
|
Corbus Pharmaceuticals Holdings, Inc.
|
-31.16 Million USD
|
232.785%
|
Aptose Biosciences Inc.
|
-474.54 Thousand USD
|
8821.196%
|
Precision BioSciences, Inc.
|
40.47 Million USD
|
-2.258%
|
Dyadic International, Inc.
|
922.95 Thousand USD
|
-4384.066%
|
TScan Therapeutics, Inc.
|
-67.1 Million USD
|
161.674%
|
Intensity Therapeutics, Inc.
|
-147 Thousand USD
|
28253.741%
|
Nektar Therapeutics
|
53.47 Million USD
|
22.611%
|
CytomX Therapeutics, Inc.
|
99.03 Million USD
|
58.212%
|
VYNE Therapeutics Inc.
|
424 Thousand USD
|
-9660.849%
|
Leap Therapeutics, Inc.
|
-427 Thousand USD
|
9792.272%
|
Adaptive Biotechnologies Corporation
|
94.72 Million USD
|
56.308%
|
GRI Bio, Inc.
|
10.84 Million USD
|
-281.754%
|
Xenetic Biosciences, Inc.
|
2.53 Million USD
|
-1529.379%
|
Tenaya Therapeutics, Inc.
|
-8.68 Million USD
|
576.413%
|
NeuroSense Therapeutics Ltd.
|
-97 Thousand USD
|
42765.979%
|
Psyence Biomedical Ltd.
|
-240.00 USD
|
17244266.667%
|
IGM Biosciences, Inc.
|
-211.66 Million USD
|
119.553%
|
INmune Bio, Inc.
|
155 Thousand USD
|
-26600.645%
|
Opthea Limited
|
21.72 Thousand USD
|
-190443.278%
|
Milestone Pharmaceuticals Inc.
|
402 Thousand USD
|
-10195.025%
|
Omega Therapeutics, Inc.
|
-62.77 Million USD
|
165.928%
|
Verastem, Inc.
|
-62 Thousand USD
|
66851.613%
|
Abeona Therapeutics Inc.
|
2.43 Million USD
|
-1599.63%
|
Pliant Therapeutics, Inc.
|
-261 Thousand USD
|
15956.705%
|
Tonix Pharmaceuticals Holding Corp.
|
3.02 Million USD
|
-1267.228%
|
Ligand Pharmaceuticals Incorporated
|
119.75 Million USD
|
65.441%
|
NextCure, Inc.
|
-3.68 Million USD
|
1223.398%
|
Inhibikase Therapeutics, Inc.
|
-13.35 Million USD
|
409.825%
|
Organovo Holdings, Inc.
|
-5.38 Million USD
|
867.972%
|
Lixte Biotechnology Holdings, Inc.
|
- USD
|
-Infinity%
|
Arvinas, Inc.
|
71.8 Million USD
|
42.359%
|
Ovid Therapeutics Inc.
|
-1.2 Million USD
|
3534.865%
|
CASI Pharmaceuticals, Inc.
|
20.05 Million USD
|
-106.393%
|
Rani Therapeutics Holdings, Inc.
|
-822 Thousand USD
|
5134.793%
|
Centessa Pharmaceuticals plc
|
6.06 Million USD
|
-582.214%
|
Arcturus Therapeutics Holdings Inc.
|
154.79 Million USD
|
73.263%
|
Syros Pharmaceuticals, Inc.
|
-98.21 Million USD
|
142.137%
|
Senti Biosciences, Inc.
|
-2.68 Million USD
|
1642.527%
|
BioRestorative Therapies, Inc.
|
145.8 Thousand USD
|
-28285.46%
|
Apollomics, Inc.
|
127 Thousand USD
|
-32487.402%
|
PureTech Health plc
|
-1.6 Million USD
|
2681.784%
|
Oncternal Therapeutics, Inc.
|
-28.96 Million USD
|
242.868%
|
Barinthus Biotherapeutics plc
|
802 Thousand USD
|
-5060.349%
|
Kymera Therapeutics, Inc.
|
-110.48 Million USD
|
137.457%
|
Synaptogenix, Inc.
|
-6347.00 USD
|
652156.089%
|
ChromaDex Corporation
|
50.78 Million USD
|
18.499%
|
Beam Therapeutics Inc.
|
-59.67 Million USD
|
169.356%
|
Monopar Therapeutics Inc.
|
- USD
|
-Infinity%
|
Akebia Therapeutics, Inc.
|
120.47 Million USD
|
65.647%
|
Nurix Therapeutics, Inc.
|
-112.16 Million USD
|
136.899%
|
Apellis Pharmaceuticals, Inc.
|
338.08 Million USD
|
87.759%
|
Dermata Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Gritstone bio, Inc.
|
-6.26 Million USD
|
761.118%
|
Mesoblast Limited
|
-9.81 Million USD
|
521.661%
|
Virpax Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Xeris Biopharma Holdings, Inc.
|
135.26 Million USD
|
69.405%
|
Fate Therapeutics, Inc.
|
-98.16 Million USD
|
142.16%
|
MediWound Ltd.
|
3.57 Million USD
|
-1056.68%
|
BioXcel Therapeutics, Inc.
|
120 Thousand USD
|
-34388.333%
|
Fortress Biotech, Inc.
|
57.85 Million USD
|
28.464%
|
Fractyl Health, Inc. Common Stock
|
43 Thousand USD
|
-96146.512%
|
Achilles Therapeutics plc
|
-4.73 Million USD
|
974.734%
|
Seres Therapeutics, Inc.
|
125.62 Million USD
|
67.055%
|
Checkpoint Therapeutics, Inc.
|
-43.46 Million USD
|
195.221%
|
Atossa Therapeutics, Inc.
|
-23 Thousand USD
|
180039.13%
|
Zai Lab Limited
|
170.9 Million USD
|
75.784%
|
Fresh Tracks Therapeutics, Inc.
|
8 Million USD
|
-416.937%
|
Lyell Immunopharma, Inc.
|
130 Thousand USD
|
-31735.385%
|
Vanda Pharmaceuticals Inc.
|
177.84 Million USD
|
76.729%
|
Tarsus Pharmaceuticals, Inc.
|
15.85 Million USD
|
-161.045%
|
InMed Pharmaceuticals Inc.
|
-6.98 Billion USD
|
100.592%
|
FibroGen, Inc.
|
128.9 Million USD
|
67.894%
|
Celcuity Inc.
|
-142.77 Thousand USD
|
29087.477%
|
SeaStar Medical Holding Corporation
|
- USD
|
-Infinity%
|
ContextLogic Inc.
|
59 Million USD
|
29.854%
|
GH Research PLC
|
-315 Thousand USD
|
13238.413%
|
HOOKIPA Pharma Inc.
|
16.57 Million USD
|
-149.659%
|
Cyclacel Pharmaceuticals, Inc.
|
389 Thousand USD
|
-10539.075%
|
ImmuCell Corporation
|
4.39 Million USD
|
-841.386%
|
Amylyx Pharmaceuticals, Inc.
|
355.34 Million USD
|
88.353%
|
Amarin Corporation plc
|
165.54 Million USD
|
75.0%
|
TG Therapeutics, Inc.
|
219.1 Million USD
|
81.112%
|
Aptevo Therapeutics Inc.
|
-567 Thousand USD
|
7399.118%
|
Jasper Therapeutics, Inc.
|
-1.1 Million USD
|
3835.199%
|
Foghorn Therapeutics Inc.
|
-75.53 Million USD
|
154.791%
|
Y-mAbs Therapeutics, Inc.
|
73.4 Million USD
|
43.618%
|
Aptorum Group Limited
|
-1.11 Million USD
|
3812.788%
|
Ultragenyx Pharmaceutical Inc.
|
389.04 Million USD
|
89.362%
|
BioCryst Pharmaceuticals, Inc.
|
326.75 Million USD
|
87.334%
|
Chemomab Therapeutics Ltd.
|
-66.82 Thousand USD
|
62030.058%
|
Arrowhead Pharmaceuticals, Inc.
|
240.73 Million USD
|
82.808%
|
TransCode Therapeutics, Inc.
|
-516.74 Thousand USD
|
8108.964%
|
RAPT Therapeutics, Inc.
|
-3.55 Million USD
|
1265.475%
|
Ardelyx, Inc.
|
106.66 Million USD
|
61.199%
|
Ainos, Inc.
|
-253.73 Thousand USD
|
16410.846%
|
Lyra Therapeutics, Inc.
|
-46.47 Million USD
|
189.058%
|
Prothena Corporation plc
|
-129.2 Million USD
|
132.032%
|
HilleVax, Inc.
|
-2.15 Million USD
|
2019.573%
|
Adaptimmune Therapeutics plc
|
50.42 Million USD
|
17.924%
|
Celularity Inc.
|
6.75 Million USD
|
-512.672%
|
Rallybio Corporation
|
-150 Thousand USD
|
27690.667%
|
Cue Biopharma, Inc.
|
-32.6 Million USD
|
226.924%
|
Omeros Corporation
|
-69.77 Million USD
|
159.31%
|
Humacyte, Inc.
|
-76.55 Million USD
|
154.064%
|
Immunocore Holdings plc
|
248.39 Million USD
|
83.338%
|
Cocrystal Pharma, Inc.
|
-15.16 Million USD
|
372.833%
|
Blueprint Medicines Corporation
|
236.58 Million USD
|
82.507%
|
IO Biotech, Inc.
|
-756 Thousand USD
|
5574.339%
|
MEI Pharma, Inc.
|
49.32 Million USD
|
16.099%
|
GT Biopharma, Inc.
|
- USD
|
-Infinity%
|
Cabaletta Bio, Inc.
|
-1.42 Million USD
|
3002.244%
|
Summit Therapeutics Inc.
|
-2.05 Million USD
|
2118.829%
|
Alaunos Therapeutics, Inc.
|
-4.79 Million USD
|
962.568%
|
Marinus Pharmaceuticals, Inc.
|
29.05 Million USD
|
-42.44%
|
Scholar Rock Holding Corporation
|
-2.84 Million USD
|
1555.204%
|
Pulmatrix, Inc.
|
-8.22 Million USD
|
603.479%
|
Elicio Therapeutics, Inc.
|
-1.17 Million USD
|
3637.265%
|
X4 Pharmaceuticals, Inc.
|
-1.99 Million USD
|
2173.447%
|
Vigil Neuroscience, Inc.
|
-399 Thousand USD
|
10472.431%
|
Acelyrin, Inc.
|
-115 Thousand USD
|
36087.826%
|
Intellia Therapeutics, Inc.
|
-398.79 Million USD
|
110.378%
|
Cytokinetics, Incorporated
|
-322.59 Million USD
|
112.829%
|
Vor Biopharma Inc.
|
-3.49 Million USD
|
1285.166%
|
Evogene Ltd.
|
1.39 Million USD
|
-2858.256%
|
Replimune Group, Inc.
|
-2.65 Million USD
|
1658.795%
|
Applied Therapeutics, Inc.
|
-43.91 Million USD
|
194.248%
|
PDS Biotechnology Corporation
|
-57.32 Thousand USD
|
72294.118%
|
Hoth Therapeutics, Inc.
|
- USD
|
-Infinity%
|
BridgeBio Pharma, Inc.
|
6.85 Million USD
|
-503.558%
|
AEON Biopharma, Inc.
|
- USD
|
-Infinity%
|
BioLineRx Ltd.
|
1.1 Million USD
|
-3635.199%
|
Galectin Therapeutics Inc.
|
-33 Thousand USD
|
125512.121%
|
Atai Life Sciences N.V.
|
-5000.00 USD
|
827820.0%
|
Aerovate Therapeutics, Inc.
|
-96 Thousand USD
|
43210.417%
|
VistaGen Therapeutics, Inc.
|
496 Thousand USD
|
-8243.952%
|
Zentalis Pharmaceuticals, Inc.
|
-1.38 Million USD
|
3079.554%
|
Sagimet Biosciences Inc.
|
2 Million USD
|
-1969.3%
|
MediciNova, Inc.
|
979.7 Thousand USD
|
-4124.333%
|
Praxis Precision Medicines, Inc.
|
-84.31 Million USD
|
149.083%
|
MiMedx Group, Inc.
|
266.84 Million USD
|
84.491%
|
Cardio Diagnostics Holdings, Inc.
|
-94.55 Thousand USD
|
43869.235%
|
Axsome Therapeutics, Inc.
|
244.53 Million USD
|
83.076%
|
PTC Therapeutics, Inc.
|
872.33 Million USD
|
95.256%
|
Mereo BioPharma Group plc
|
7.42 Million USD
|
-457.312%
|
Syndax Pharmaceuticals, Inc.
|
-12 Thousand USD
|
344983.333%
|
NRx Pharmaceuticals, Inc.
|
-5000.00 USD
|
827820.0%
|
Dyne Therapeutics, Inc.
|
-2.46 Million USD
|
1781.674%
|
BriaCell Therapeutics Corp.
|
- USD
|
-Infinity%
|
Allakos Inc.
|
-6.14 Million USD
|
773.929%
|
scPharmaceuticals Inc.
|
9.78 Million USD
|
-323.083%
|
Fulcrum Therapeutics, Inc.
|
-68.99 Million USD
|
159.983%
|
Corcept Therapeutics Incorporated
|
475.89 Million USD
|
91.304%
|
NLS Pharmaceutics AG
|
-11.4 Thousand USD
|
362880.505%
|
Precigen, Inc.
|
106 Thousand USD
|
-38943.396%
|
XOMA Corporation
|
3.86 Million USD
|
-971.898%
|
Kezar Life Sciences, Inc.
|
-70.08 Million USD
|
159.051%
|
Incyte Corporation
|
3.44 Billion USD
|
98.797%
|
Alzamend Neuro, Inc.
|
-50.74 Thousand USD
|
81664.84%
|
Cara Therapeutics, Inc.
|
14.79 Million USD
|
-179.749%
|
Aligos Therapeutics, Inc.
|
12.46 Million USD
|
-232.151%
|
Seer, Inc.
|
7.02 Million USD
|
-488.957%
|
Reviva Pharmaceuticals Holdings, Inc.
|
- USD
|
-Infinity%
|
CRISPR Therapeutics AG
|
240.95 Million USD
|
82.824%
|
Akero Therapeutics, Inc.
|
-29 Thousand USD
|
142810.345%
|
Eliem Therapeutics, Inc.
|
- USD
|
-Infinity%
|
EyeGate Pharmaceuticals, Inc.
|
13.00 USD
|
-318353746.154%
|
Akari Therapeutics, Plc
|
-4000.00 USD
|
1034750.0%
|
Novavax, Inc.
|
639.93 Million USD
|
93.533%
|
Lexaria Bioscience Corp.
|
194.7 Thousand USD
|
-21155.418%
|
UroGen Pharma Ltd.
|
73.35 Million USD
|
43.579%
|
Sutro Biopharma, Inc.
|
-26.69 Million USD
|
255.039%
|
Entera Bio Ltd.
|
-56 Thousand USD
|
74003.571%
|
Lisata Therapeutics, Inc.
|
-189 Thousand USD
|
21997.354%
|
Stoke Therapeutics, Inc.
|
4.05 Million USD
|
-921.624%
|
Chimerix, Inc.
|
324 Thousand USD
|
-12673.457%
|
Reneo Pharmaceuticals, Inc.
|
-525 Thousand USD
|
7983.048%
|
Phathom Pharmaceuticals, Inc.
|
515 Thousand USD
|
-7936.117%
|
Outlook Therapeutics, Inc.
|
-44.18 Thousand USD
|
93758.912%
|
Jazz Pharmaceuticals plc
|
3.39 Billion USD
|
98.782%
|
AnaptysBio, Inc.
|
14.78 Million USD
|
-179.995%
|
Aprea Therapeutics, Inc.
|
576.17 Thousand USD
|
-7082.837%
|
Portage Biotech Inc.
|
-54 Thousand USD
|
76740.741%
|
Olema Pharmaceuticals, Inc.
|
-377 Thousand USD
|
11077.719%
|
PMV Pharmaceuticals, Inc.
|
-1.25 Million USD
|
3392.442%
|
OKYO Pharma Limited
|
-7506.16 USD
|
551460.483%
|
Qualigen Therapeutics, Inc.
|
-4495.00 USD
|
920811.902%
|
Cadrenal Therapeutics, Inc. Common Stock
|
-1980.00 USD
|
2090302.02%
|
Processa Pharmaceuticals, Inc.
|
-222.00 USD
|
18642442.342%
|
AbCellera Biologics Inc.
|
38.02 Million USD
|
-8.839%
|
Genprex, Inc.
|
-15 Thousand USD
|
275933.111%
|
Neumora Therapeutics, Inc. Common Stock
|
-668 Thousand USD
|
6295.509%
|
NLS Pharmaceutics AG
|
-11.4 Thousand USD
|
362880.505%
|
Virios Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Daré Bioscience, Inc.
|
2.76 Million USD
|
-1394.337%
|
Titan Pharmaceuticals, Inc.
|
-1.72 Million USD
|
2493.638%
|
Bicycle Therapeutics plc
|
-129.52 Million USD
|
131.953%
|
Revolution Medicines, Inc. Warrant
|
-399.66 Million USD
|
110.355%
|
Protagonist Therapeutics, Inc.
|
56.68 Million USD
|
26.993%
|
Erasca, Inc.
|
-3.73 Million USD
|
1208.95%
|
bluebird bio, Inc.
|
-4.03 Million USD
|
1126.948%
|
Pieris Pharmaceuticals, Inc.
|
1 Million USD
|
-4001.685%
|
BioMarin Pharmaceutical Inc.
|
1.9 Billion USD
|
97.827%
|
DBV Technologies S.A.
|
15.72 Million USD
|
-163.136%
|
Fortress Biotech, Inc.
|
57.85 Million USD
|
28.464%
|
Avidity Biosciences, Inc.
|
-181.4 Million USD
|
122.814%
|
CorMedix Inc.
|
-205.56 Thousand USD
|
20233.099%
|
Travere Therapeutics, Inc.
|
133.78 Million USD
|
69.066%
|
Sensei Biotherapeutics, Inc.
|
-571 Thousand USD
|
7347.986%
|
Orchestra BioMed Holdings, Inc.
|
2.57 Million USD
|
-1507.848%
|
Spruce Biosciences, Inc.
|
-39.34 Million USD
|
205.193%
|
Celldex Therapeutics, Inc.
|
-111.12 Million USD
|
137.242%
|
Cartesian Therapeutics, Inc.
|
24.45 Million USD
|
-69.261%
|
Cogent Biosciences, Inc.
|
-3.58 Million USD
|
1253.456%
|
Onconetix, Inc.
|
-1.12 Million USD
|
3771.69%
|
Ocuphire Pharma, Inc.
|
19.04 Million USD
|
-117.329%
|
Prime Medicine, Inc.
|
-147.9 Million USD
|
127.981%
|
Adagene Inc.
|
18.11 Million USD
|
-128.507%
|
Inhibrx Biosciences, Inc.
|
609 Thousand USD
|
-6695.731%
|
GlycoMimetics, Inc.
|
-143.3 Thousand USD
|
28980.468%
|
Maravai LifeSciences Holdings, Inc.
|
140.2 Million USD
|
70.481%
|
Verve Therapeutics, Inc.
|
-173.18 Million USD
|
123.897%
|
Voyager Therapeutics, Inc.
|
157.83 Million USD
|
73.779%
|
SciSparc Ltd.
|
2.19 Million USD
|
-1784.608%
|
Revelation Biosciences, Inc.
|
-25.04 Thousand USD
|
165320.168%
|
Minerva Neurosciences, Inc.
|
-30.98 Thousand USD
|
133680.789%
|
Astria Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Spero Therapeutics, Inc.
|
96.36 Million USD
|
57.054%
|
Tevogen Bio Holdings Inc.
|
- USD
|
-Infinity%
|
Arcutis Biotherapeutics, Inc.
|
54.61 Million USD
|
24.228%
|
Marker Therapeutics, Inc.
|
-7.1 Million USD
|
682.437%
|
Alnylam Pharmaceuticals, Inc.
|
1.51 Billion USD
|
97.273%
|
Artelo Biosciences, Inc.
|
- USD
|
-Infinity%
|
2seventy bio, Inc.
|
98.28 Million USD
|
57.893%
|
ADMA Biologics, Inc.
|
88.21 Million USD
|
53.087%
|
Clene Inc.
|
533 Thousand USD
|
-7664.728%
|
Capricor Therapeutics, Inc.
|
24.1 Million USD
|
-71.661%
|
Boundless Bio, Inc. Common Stock
|
-957 Thousand USD
|
4424.556%
|
Recursion Pharmaceuticals, Inc.
|
1.98 Million USD
|
-1981.791%
|
Citius Pharmaceuticals, Inc.
|
-194.31 Thousand USD
|
21398.298%
|
Contineum Therapeutics, Inc. Class A Common Stock
|
49.8 Million USD
|
16.904%
|
Absci Corporation
|
-41.84 Million USD
|
198.894%
|
Regeneron Pharmaceuticals, Inc.
|
11.3 Billion USD
|
99.634%
|
Surrozen, Inc.
|
-27.23 Million USD
|
251.987%
|
Caribou Biosciences, Inc.
|
-77.59 Million USD
|
153.334%
|
Janux Therapeutics, Inc.
|
-46.83 Million USD
|
188.358%
|
Cingulate Inc.
|
-582.91 Thousand USD
|
7199.798%
|
Galmed Pharmaceuticals Ltd.
|
-31 Thousand USD
|
133603.226%
|
Tenax Therapeutics, Inc.
|
-7570.00 USD
|
546810.7%
|
Jaguar Health, Inc.
|
7.72 Million USD
|
-435.81%
|
Terns Pharmaceuticals, Inc.
|
-881 Thousand USD
|
4797.616%
|
ACADIA Pharmaceuticals Inc.
|
680.7 Million USD
|
93.92%
|
Kronos Bio, Inc.
|
1.37 Million USD
|
-2916.472%
|
Innoviva, Inc.
|
261.06 Million USD
|
84.147%
|
Bolt Biotherapeutics, Inc.
|
-53.66 Million USD
|
177.118%
|
Entrada Therapeutics, Inc.
|
29.12 Million USD
|
-42.078%
|
ZyVersa Therapeutics, Inc.
|
-10.4 Thousand USD
|
398042.308%
|
Soligenix, Inc.
|
97.31 Thousand USD
|
-42429.622%
|
AlloVir, Inc.
|
-398 Thousand USD
|
10498.492%
|
Century Therapeutics, Inc.
|
-10.8 Million USD
|
482.885%
|
ORIC Pharmaceuticals, Inc.
|
-1.03 Million USD
|
4110.271%
|
Kura Oncology, Inc.
|
-849 Thousand USD
|
4974.676%
|
Ocean Biomedical, Inc.
|
- USD
|
-Infinity%
|
Mineralys Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Eterna Therapeutics Inc.
|
-168 Thousand USD
|
24734.524%
|
SELLAS Life Sciences Group, Inc.
|
- USD
|
-Infinity%
|
Heron Therapeutics, Inc.
|
61.93 Million USD
|
33.183%
|
SAB Biotherapeutics, Inc.
|
-1.5 Million USD
|
2847.543%
|
Pasithea Therapeutics Corp.
|
-648.45 Thousand USD
|
6482.257%
|
Entero Therapeutics, Inc.
|
-29.27 Thousand USD
|
141474.599%
|
HCW Biologics Inc.
|
-574.82 Thousand USD
|
7299.769%
|
C4 Therapeutics, Inc.
|
-96.95 Million USD
|
142.688%
|
Atara Biotherapeutics, Inc.
|
-313 Thousand USD
|
13322.364%
|
Coherus BioSciences, Inc.
|
94.46 Million USD
|
56.187%
|
Lantern Pharma Inc.
|
-174.84 Thousand USD
|
23770.379%
|
Histogen Inc.
|
3.76 Million USD
|
-998.063%
|
Surrozen, Inc.
|
-27.23 Million USD
|
251.987%
|
Eledon Pharmaceuticals, Inc.
|
-374 Thousand USD
|
11165.775%
|
Kodiak Sciences Inc.
|
-25.94 Million USD
|
259.502%
|
MoonLake Immunotherapeutics
|
-13.15 Thousand USD
|
314631.084%
|
Hepion Pharmaceuticals, Inc.
|
-67.13 Thousand USD
|
61749.61%
|
Adverum Biotechnologies, Inc.
|
-2.04 Million USD
|
2124.755%
|
Avalo Therapeutics, Inc.
|
640 Thousand USD
|
-6366.563%
|
Moderna, Inc.
|
2.15 Billion USD
|
98.08%
|
Ionis Pharmaceuticals, Inc.
|
778.51 Million USD
|
94.684%
|
Turnstone Biologics Corp.
|
16.5 Million USD
|
-150.733%
|
Immix Biopharma, Inc.
|
-5468.00 USD
|
756976.372%
|
Tiziana Life Sciences Ltd
|
-51 Thousand USD
|
81249.02%
|
Aurinia Pharmaceuticals Inc.
|
161.36 Million USD
|
74.353%
|
Exelixis, Inc.
|
1.75 Billion USD
|
97.645%
|
Monte Rosa Therapeutics, Inc.
|
-6.22 Million USD
|
765.156%
|
Wave Life Sciences Ltd.
|
104.09 Million USD
|
60.244%
|
Conduit Pharmaceuticals Inc.
|
- USD
|
-Infinity%
|
Alkermes plc
|
1.37 Billion USD
|
96.989%
|
Jasper Therapeutics, Inc.
|
-1.1 Million USD
|
3835.199%
|
Arcellx, Inc.
|
108.27 Million USD
|
61.778%
|
ESSA Pharma Inc.
|
-118.49 Thousand USD
|
35027.547%
|
TNF Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Avid Bioservices, Inc.
|
7.31 Million USD
|
-465.537%
|
Insmed Incorporated
|
239.63 Million USD
|
82.73%
|
Cardiff Oncology, Inc.
|
-32.36 Million USD
|
227.857%
|
Enanta Pharmaceuticals, Inc.
|
79.2 Million USD
|
47.748%
|
Moolec Science SA
|
-143.3 Thousand USD
|
28979.662%
|
RenovoRx, Inc.
|
- USD
|
-Infinity%
|
Acumen Pharmaceuticals, Inc.
|
-42.31 Million USD
|
197.798%
|
Geron Corporation
|
-123.5 Million USD
|
133.51%
|
LAVA Therapeutics N.V.
|
3.28 Million USD
|
-1159.081%
|
Verrica Pharmaceuticals Inc.
|
4.37 Million USD
|
-845.317%
|
Royalty Pharma plc
|
1.79 Billion USD
|
97.693%
|
OmniAb, Inc.
|
14.66 Million USD
|
-182.171%
|
Alector, Inc.
|
-95.05 Million USD
|
143.54%
|
Atea Pharmaceuticals, Inc.
|
-70.09 Million USD
|
159.047%
|
Mersana Therapeutics, Inc.
|
-111.41 Million USD
|
137.146%
|
Humacyte, Inc.
|
-76.55 Million USD
|
154.064%
|
Structure Therapeutics Inc.
|
-949.17 Thousand USD
|
4460.212%
|
Revance Therapeutics, Inc.
|
81.87 Million USD
|
49.453%
|
89bio, Inc.
|
-273 Thousand USD
|
15259.707%
|
Avenue Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Aura Biosciences, Inc.
|
-1.29 Million USD
|
3295.83%
|
Immunic, Inc.
|
-111 Thousand USD
|
37384.685%
|
Veracyte, Inc.
|
248.14 Million USD
|
83.322%
|
Genelux Corporation
|
-848 Thousand USD
|
4980.425%
|
Trevi Therapeutics, Inc.
|
-123 Thousand USD
|
33747.154%
|
Adial Pharmaceuticals, Inc.
|
-564.00 USD
|
7338043.262%
|
Sonnet BioTherapeutics Holdings, Inc.
|
-11.66 Million USD
|
454.731%
|
Immunovant, Inc.
|
-231 Thousand USD
|
18016.017%
|
Vericel Corporation
|
135.57 Million USD
|
69.474%
|
Fortrea Holdings Inc.
|
424 Million USD
|
90.239%
|
KalVista Pharmaceuticals, Inc.
|
-86.16 Million USD
|
148.03%
|
XBiotech Inc.
|
-1.74 Million USD
|
2473.05%
|
Agenus Inc.
|
139.61 Million USD
|
70.357%
|
Acasti Pharma Inc.
|
-11 Thousand USD
|
376336.364%
|
Kiora Pharmaceuticals, Inc.
|
-4.02 Million USD
|
1127.703%
|
MiNK Therapeutics, Inc.
|
-204.61 Thousand USD
|
20326.081%
|
Pasithea Therapeutics Corp.
|
-648.45 Thousand USD
|
6482.257%
|
Theravance Biopharma, Inc.
|
16.8 Million USD
|
-146.301%
|
Metagenomi, Inc. Common Stock
|
-49.64 Million USD
|
183.361%
|
NeuroBo Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Gain Therapeutics, Inc.
|
-11.32 Million USD
|
465.477%
|
Tempest Therapeutics, Inc.
|
-381 Thousand USD
|
10962.467%
|
Sol-Gel Technologies Ltd.
|
-21.98 Million USD
|
288.229%
|
Rhythm Pharmaceuticals, Inc.
|
68.12 Million USD
|
39.251%
|
United Therapeutics Corporation
|
2.07 Billion USD
|
98.001%
|
Creative Medical Technology Holdings, Inc.
|
5400.00 USD
|
-766307.407%
|
BriaCell Therapeutics Corp.
|
-82.58 Thousand USD
|
50214.43%
|
Lixte Biotechnology Holdings, Inc.
|
- USD
|
-Infinity%
|
Silo Pharma, Inc.
|
66.26 Thousand USD
|
-62356.236%
|
Telomir Pharmaceuticals, Inc. Common Stock
|
-3.94 Million USD
|
1149.86%
|
Pharming Group N.V.
|
220.1 Million USD
|
81.197%
|
XOMA Corporation
|
3.86 Million USD
|
-971.898%
|
Reviva Pharmaceuticals Holdings, Inc.
|
- USD
|
-Infinity%
|
Bionomics Limited
|
-434.44 Thousand USD
|
9626.089%
|
Alpha Tau Medical Ltd.
|
-1.07 Million USD
|
3953.445%
|
Pyxis Oncology, Inc.
|
-2 Million USD
|
2169.3%
|
uniQure N.V.
|
2.21 Million USD
|
-1768.442%
|
Xilio Therapeutics, Inc.
|
-1.9 Million USD
|
2278.211%
|
Cassava Sciences, Inc.
|
-89.42 Million USD
|
146.281%
|
60 Degrees Pharmaceuticals, Inc.
|
-220.97 Thousand USD
|
18828.646%
|
Windtree Therapeutics, Inc.
|
-82 Thousand USD
|
50570.732%
|
Poseida Therapeutics, Inc.
|
-92.06 Million USD
|
144.951%
|
Pluri Inc.
|
322 Thousand USD
|
-12752.795%
|
Anebulo Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
MeiraGTx Holdings plc
|
287 Thousand USD
|
-14320.209%
|
Cidara Therapeutics, Inc.
|
62.38 Million USD
|
33.657%
|
ProMIS Neurosciences, Inc.
|
-10.44 Million USD
|
496.229%
|
CalciMedica, Inc.
|
-58 Thousand USD
|
71455.172%
|
Sana Biotechnology, Inc.
|
-30.86 Million USD
|
234.087%
|
Amicus Therapeutics, Inc.
|
362.03 Million USD
|
88.568%
|
Salarius Pharmaceuticals, Inc.
|
-10.05 Thousand USD
|
411860.024%
|
Alpha Tau Medical Ltd.
|
-1.07 Million USD
|
3953.445%
|
Adlai Nortye Ltd. American Depositary Shares
|
2.77 Million USD
|
-1391.073%
|
Nutriband Inc.
|
862.1 Thousand USD
|
-4700.575%
|
Protara Therapeutics, Inc.
|
-341 Thousand USD
|
12236.657%
|
Compugen Ltd.
|
31.45 Million USD
|
-31.572%
|
Roivant Sciences Ltd.
|
109.23 Million USD
|
62.113%
|
ProKidney Corp.
|
-3.16 Million USD
|
1405.964%
|
Protagenic Therapeutics, Inc.
|
-28.21 Thousand USD
|
146765.249%
|
Elevai Labs, Inc. Common Stock
|
1.13 Million USD
|
-3547.693%
|
Tango Therapeutics, Inc.
|
-78.67 Million USD
|
152.606%
|
Renovaro Biosciences Inc.
|
-121.85 Thousand USD
|
34062.202%
|
Zevra Therapeutics, Inc.
|
24.51 Million USD
|
-68.812%
|
Benitec Biopharma Inc.
|
108 Thousand USD
|
-38220.37%
|
GeoVax Labs, Inc.
|
-20.72 Million USD
|
299.732%
|
Biomea Fusion, Inc.
|
-4.2 Million USD
|
1085.146%
|
Cullinan Oncology, Inc.
|
-310 Thousand USD
|
13450.323%
|
4D Molecular Therapeutics, Inc.
|
-76.37 Million USD
|
154.189%
|
Kiniksa Pharmaceuticals, Ltd.
|
213.73 Million USD
|
80.637%
|
Nuvectis Pharma, Inc.
|
-22.89 Million USD
|
280.749%
|
Spyre Therapeutics, Inc.
|
-78 Thousand USD
|
53158.974%
|
Ventyx Biosciences, Inc.
|
-941 Thousand USD
|
4498.087%
|
Imunon, Inc.
|
-720 Thousand USD
|
5848.016%
|
BioAtla, Inc.
|
-103.73 Million USD
|
139.897%
|
Allogene Therapeutics, Inc.
|
-242.81 Million USD
|
117.044%
|
Larimar Therapeutics, Inc.
|
-311 Thousand USD
|
13407.395%
|
Zura Bio Limited
|
- USD
|
-Infinity%
|
aTyr Pharma, Inc.
|
-2.38 Million USD
|
1833.082%
|
Madrigal Pharmaceuticals, Inc.
|
-527 Thousand USD
|
7953.131%
|
Viridian Therapeutics, Inc.
|
-1 Million USD
|
4205.754%
|
Galecto, Inc.
|
-830 Thousand USD
|
5086.265%
|
Tevogen Bio Holdings Inc.
|
- USD
|
-Infinity%
|
Halozyme Therapeutics, Inc.
|
636.89 Million USD
|
93.502%
|
Lexicon Pharmaceuticals, Inc.
|
1.11 Million USD
|
-3598.481%
|
PolyPid Ltd.
|
-1.82 Million USD
|
2371.46%
|
Aileron Therapeutics, Inc.
|
-119 Thousand USD
|
34878.151%
|
Forte Biosciences, Inc.
|
-9000.00 USD
|
459944.444%
|
Xencor, Inc.
|
-85.26 Million USD
|
148.541%
|
Coeptis Therapeutics Holdings, Inc.
|
-1 Million USD
|
4233.491%
|
Lexaria Bioscience Corp.
|
194.7 Thousand USD
|
-21155.418%
|
Instil Bio, Inc.
|
-4.75 Million USD
|
970.185%
|
Cardio Diagnostics Holdings, Inc.
|
-94.55 Thousand USD
|
43869.235%
|
OncoCyte Corporation
|
413 Thousand USD
|
-9920.823%
|
Elevation Oncology, Inc.
|
-39 Thousand USD
|
106217.949%
|
Purple Biotech Ltd.
|
-196 Thousand USD
|
21215.306%
|
CollPlant Biotechnologies Ltd.
|
8.96 Million USD
|
-361.485%
|
MacroGenics, Inc.
|
50.52 Million USD
|
18.091%
|
Verona Pharma plc
|
-679.62 Thousand USD
|
6189.544%
|
Tharimmune, Inc.
|
- USD
|
-Infinity%
|
Apogee Therapeutics, Inc.
|
- USD
|
-Infinity%
|
enGene Holdings Inc. Warrants
|
-175 Thousand USD
|
23749.143%
|
Aditxt, Inc.
|
-111.66 Thousand USD
|
37164.302%
|
XTL Biopharmaceuticals Ltd.
|
- USD
|
-Infinity%
|
Savara Inc.
|
-44.26 Million USD
|
193.502%
|
Curis, Inc.
|
9.81 Million USD
|
-321.833%
|
Carmell Therapeutics Corporation
|
-124.78 Thousand USD
|
33265.048%
|
Achieve Life Sciences, Inc.
|
-228 Thousand USD
|
18251.754%
|
BeiGene, Ltd.
|
2.07 Billion USD
|
98.009%
|
Protagenic Therapeutics, Inc.
|
-28.21 Thousand USD
|
146765.249%
|
Vincerx Pharma, Inc.
|
-915 Thousand USD
|
4623.06%
|
Plus Therapeutics, Inc.
|
-4.77 Million USD
|
966.36%
|
Acrivon Therapeutics, Inc. Common Stock
|
-536 Thousand USD
|
7821.269%
|
Rigel Pharmaceuticals, Inc.
|
109.77 Million USD
|
62.298%
|
Adicet Bio, Inc.
|
-6.09 Million USD
|
778.682%
|
Estrella Immunopharma, Inc.
|
- USD
|
-Infinity%
|
Quantum-Si incorporated
|
488 Thousand USD
|
-8380.738%
|
Acurx Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Generation Bio Co.
|
-73.91 Million USD
|
155.994%
|
Black Diamond Therapeutics, Inc.
|
-437 Thousand USD
|
9570.481%
|
Invivyd, Inc.
|
-2.02 Million USD
|
2140.73%
|
Relay Therapeutics, Inc.
|
-300.84 Million USD
|
113.757%
|
Quoin Pharmaceuticals, Ltd.
|
-103.43 Thousand USD
|
40110.441%
|
Moolec Science SA
|
-143.3 Thousand USD
|
28979.662%
|
Clearside Biomedical, Inc.
|
7.87 Million USD
|
-425.804%
|
Longboard Pharmaceuticals, Inc.
|
-5000.00 USD
|
827820.0%
|
Relmada Therapeutics, Inc.
|
- USD
|
-Infinity%
|
ALX Oncology Holdings Inc.
|
-836 Thousand USD
|
5050.478%
|
Vir Biotechnology, Inc.
|
83.41 Million USD
|
50.385%
|
Evaxion Biotech A/S
|
73.11 Thousand USD
|
-56506.303%
|
Ocular Therapeutix, Inc.
|
53.16 Million USD
|
22.151%
|
Tyra Biosciences, Inc.
|
-353 Thousand USD
|
11824.079%
|
Unity Biotechnology, Inc.
|
-19.69 Million USD
|
310.092%
|
Connect Biopharma Holdings Limited
|
-988 Thousand USD
|
4288.866%
|
Clearmind Medicine Inc.
|
-56.34 Thousand USD
|
73554.971%
|
Aadi Bioscience, Inc.
|
21.54 Million USD
|
-92.091%
|
Catalyst Pharmaceuticals, Inc.
|
313.67 Million USD
|
86.806%
|
CERo Therapeutics Holdings, Inc.
|
- USD
|
-Infinity%
|
Viking Therapeutics, Inc.
|
-292 Thousand USD
|
14273.288%
|
Keros Therapeutics, Inc.
|
-664 Thousand USD
|
6332.831%
|
Crinetics Pharmaceuticals, Inc.
|
4.01 Million USD
|
-931.298%
|
ImmunityBio, Inc.
|
-17.89 Million USD
|
331.336%
|
Korro Bio, Inc.
|
-3.63 Million USD
|
1240.11%
|
Kineta, Inc.
|
5.43 Million USD
|
-661.752%
|
BioVie Inc.
|
-229.37 Thousand USD
|
18142.785%
|
Codexis, Inc.
|
57.33 Million USD
|
27.816%
|
Celularity Inc.
|
6.75 Million USD
|
-512.672%
|
Virax Biolabs Group Limited
|
50.59 Thousand USD
|
-81706.681%
|
Cibus, Inc.
|
1.42 Million USD
|
-2810.408%
|
Annexon, Inc.
|
-3.26 Million USD
|
1366.789%
|
Assembly Biosciences, Inc.
|
-41.73 Million USD
|
199.159%
|
Eyenovia, Inc.
|
- USD
|
-Infinity%
|
Puma Biotechnology, Inc.
|
172.95 Million USD
|
76.071%
|
NeurAxis, Inc.
|
2.15 Million USD
|
-1818.947%
|
Regulus Therapeutics Inc.
|
-21.15 Million USD
|
295.66%
|
Compass Therapeutics, Inc.
|
-1.89 Million USD
|
2289.735%
|
TFF Pharmaceuticals, Inc.
|
231.39 Thousand USD
|
-17785.743%
|
Notable Labs, Ltd.
|
113 Thousand USD
|
-36524.779%
|
IN8bio, Inc.
|
-2.5 Million USD
|
1754.778%
|
DiaMedica Therapeutics Inc.
|
-30 Thousand USD
|
138053.333%
|
Vera Therapeutics, Inc.
|
1.86 Million USD
|
-2122.664%
|
Lumos Pharma, Inc.
|
2 Million USD
|
-1962.083%
|
Liquidia Corporation
|
14.6 Million USD
|
-183.466%
|
Mustang Bio, Inc.
|
-2.22 Million USD
|
1960.045%
|
Quantum-Si incorporated
|
488 Thousand USD
|
-8380.738%
|
Arbutus Biopharma Corporation
|
-55.55 Million USD
|
174.49%
|
enGene Holdings Inc. Common Stock
|
-175 Thousand USD
|
23749.143%
|
ARS Pharmaceuticals, Inc.
|
-20.03 Million USD
|
306.558%
|
180 Life Sciences Corp.
|
-105.67 Thousand USD
|
39263.473%
|
Vaxcyte, Inc.
|
-75 Million USD
|
155.181%
|
Xenon Pharmaceuticals Inc.
|
-167.51 Million USD
|
124.706%
|
Estrella Immunopharma, Inc.
|
- USD
|
-Infinity%
|
NKGen Biotech, Inc. Warrants
|
-1.2 Million USD
|
3540.233%
|
Opiant Pharmaceuticals, Inc.
|
31.65 Million USD
|
-30.725%
|
CERo Therapeutics Holdings, Inc.
|
- USD
|
-Infinity%
|
Soleno Therapeutics, Inc.
|
-1.95 Million USD
|
2213.687%
|
PepGen Inc.
|
-1.18 Million USD
|
3595.439%
|
Moleculin Biotech, Inc.
|
-127 Thousand USD
|
32687.402%
|
Solid Biosciences Inc.
|
-76.56 Million USD
|
154.055%
|
Palisade Bio, Inc.
|
246 Thousand USD
|
-16723.577%
|
Nutriband Inc.
|
862.1 Thousand USD
|
-4700.575%
|
Conduit Pharmaceuticals Inc.
|
- USD
|
-Infinity%
|
Immuneering Corporation
|
-764.13 Thousand USD
|
5516.037%
|
Belite Bio, Inc
|
-399 Thousand USD
|
10472.431%
|
CG Oncology, Inc. Common stock
|
-45.54 Million USD
|
190.862%
|
GeoVax Labs, Inc.
|
-20.72 Million USD
|
299.732%
|
Tourmaline Bio, Inc.
|
-33 Thousand USD
|
125512.121%
|
Altimmune, Inc.
|
-65.37 Million USD
|
163.307%
|
Peak Bio, Inc.
|
367.76 Thousand USD
|
-11153.26%
|
SeaStar Medical Holding Corporation
|
- USD
|
-Infinity%
|
FibroBiologics, Inc. Common Stock
|
-437 Thousand USD
|
9570.481%
|
Neurogene Inc.
|
-3.26 Million USD
|
1368.731%
|
Mirum Pharmaceuticals, Inc.
|
139.33 Million USD
|
70.297%
|
Kintara Therapeutics, Inc.
|
-55 Thousand USD
|
75347.273%
|
CARGO Therapeutics, Inc. Common Stock
|
-3.69 Million USD
|
1220.964%
|
Sesen Bio, Inc.
|
40 Million USD
|
-3.465%
|
argenx SE
|
1.1 Billion USD
|
96.266%
|
NKGen Biotech, Inc. Common Stock
|
-1.2 Million USD
|
3540.233%
|
Dianthus Therapeutics, Inc.
|
2.47 Million USD
|
-1574.868%
|
Immunome, Inc.
|
-8.9 Million USD
|
564.646%
|
Enveric Biosciences, Inc.
|
-408.03 Thousand USD
|
10242.882%
|
Design Therapeutics, Inc.
|
-537 Thousand USD
|
7806.89%
|
Seelos Therapeutics, Inc.
|
2.14 Million USD
|
-1828.518%
|
Enliven Therapeutics, Inc.
|
-297 Thousand USD
|
14034.68%
|
Iovance Biotherapeutics, Inc.
|
-9.56 Million USD
|
532.636%
|
Taysha Gene Therapies, Inc.
|
14.08 Million USD
|
-193.935%
|
Inovio Pharmaceuticals, Inc.
|
-2.67 Million USD
|
1649.151%
|
Athira Pharma, Inc.
|
-969 Thousand USD
|
4371.001%
|
XOMA Corporation
|
3.86 Million USD
|
-971.898%
|
Merus N.V.
|
-83.46 Million USD
|
149.587%
|
Quince Therapeutics, Inc.
|
-322 Thousand USD
|
12952.795%
|
Rezolute, Inc.
|
-36 Thousand USD
|
115061.111%
|
Clene Inc.
|
533 Thousand USD
|
-7664.728%
|
Indaptus Therapeutics, Inc.
|
-1284.00 USD
|
3223308.723%
|
BeyondSpring Inc.
|
1.75 Million USD
|
-2263.564%
|
Synlogic, Inc.
|
-1.92 Million USD
|
2251.04%
|
Allarity Therapeutics, Inc.
|
-37 Thousand USD
|
111954.054%
|
Phio Pharmaceuticals Corp.
|
-6.33 Million USD
|
753.601%
|
Peak Bio, Inc.
|
367.76 Thousand USD
|
-11153.26%
|
Werewolf Therapeutics, Inc.
|
-18.96 Million USD
|
318.246%
|
Krystal Biotech, Inc.
|
47.6 Million USD
|
13.064%
|
Karyopharm Therapeutics Inc.
|
141.09 Million USD
|
70.667%
|
SpringWorks Therapeutics, Inc.
|
5.02 Million USD
|
-723.602%
|
Lipella Pharmaceuticals Inc.
|
-2.58 Million USD
|
1698.397%
|
MannKind Corporation
|
136.19 Million USD
|
69.612%
|
Ikena Oncology, Inc.
|
-50.49 Million USD
|
181.965%
|
Cyclerion Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Gyre Therapeutics, Inc.
|
108.81 Million USD
|
61.966%
|
Gossamer Bio, Inc.
|
-4.38 Million USD
|
1043.808%
|
CohBar, Inc.
|
- USD
|
-Infinity%
|
Cognition Therapeutics, Inc.
|
-252 Thousand USD
|
16523.016%
|
NRx Pharmaceuticals, Inc.
|
-5000.00 USD
|
827820.0%
|
Legend Biotech Corporation
|
140.92 Million USD
|
70.633%
|
Mural Oncology plc
|
-2.56 Million USD
|
1712.232%
|
Disc Medicine, Inc.
|
-100 Thousand USD
|
41486.0%
|
Champions Oncology, Inc.
|
20.75 Million USD
|
-99.412%
|
REGENXBIO Inc.
|
53.02 Million USD
|
21.956%
|
Ensysce Biosciences, Inc.
|
-5.35 Million USD
|
872.566%
|
Anavex Life Sciences Corp.
|
- USD
|
-Infinity%
|
Cellectar Biosciences, Inc.
|
-192.37 Thousand USD
|
21613.19%
|
Edgewise Therapeutics, Inc.
|
-1.73 Million USD
|
2489.492%
|
Vaxart, Inc.
|
-60.76 Million USD
|
168.111%
|
PharmaCyte Biotech, Inc.
|
- USD
|
-Infinity%
|
Aldeyra Therapeutics, Inc.
|
-262.78 Thousand USD
|
15849.296%
|
Cellectis S.A.
|
18 Thousand USD
|
-229822.222%
|
Longeveron Inc.
|
221 Thousand USD
|
-18626.697%
|
Repare Therapeutics Inc.
|
-80.07 Million USD
|
151.687%
|
Sarepta Therapeutics, Inc.
|
1.09 Billion USD
|
96.214%
|
Inozyme Pharma, Inc.
|
-1.29 Million USD
|
3298.3%
|
Revolution Medicines, Inc.
|
-399.66 Million USD
|
110.355%
|
Nymox Pharmaceutical Corporation
|
- USD
|
-Infinity%
|
Third Harmonic Bio, Inc.
|
-35 Thousand USD
|
118345.714%
|
ArriVent BioPharma, Inc. Common Stock
|
- USD
|
-Infinity%
|
AN2 Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Anixa Biosciences, Inc.
|
49 Thousand USD
|
-84361.224%
|
Vertex Pharmaceuticals Incorporated
|
8.6 Billion USD
|
99.519%
|
Denali Therapeutics Inc.
|
-93.34 Million USD
|
144.337%
|
Revelation Biosciences, Inc.
|
-25.04 Thousand USD
|
165320.168%
|
Veru Inc.
|
7.56 Million USD
|
-447.005%
|
Corvus Pharmaceuticals, Inc.
|
-151 Thousand USD
|
27507.947%
|
Cingulate Inc.
|
-582.91 Thousand USD
|
7199.798%
|
Passage Bio, Inc.
|
-3.72 Million USD
|
1212.228%
|
Context Therapeutics Inc.
|
-12.04 Thousand USD
|
343723.381%
|
Exicure, Inc.
|
-1.42 Million USD
|
3008.363%
|
Day One Biopharmaceuticals, Inc.
|
-383 Thousand USD
|
10905.744%
|
Oramed Pharmaceuticals Inc.
|
2.7 Million USD
|
-1431.114%
|
Scinai Immunotherapeutics Ltd.
|
-512.67 Thousand USD
|
8172.561%
|
Nuvalent, Inc.
|
- USD
|
-Infinity%
|
ABVC BioPharma, Inc.
|
-149.6 Thousand USD
|
27763.144%
|
Carisma Therapeutics, Inc.
|
-59.2 Million USD
|
169.902%
|
Unicycive Therapeutics, Inc.
|
391 Thousand USD
|
-10484.655%
|
OmniAb, Inc.
|
14.66 Million USD
|
-182.171%
|
Anew Medical, Inc.
|
- USD
|
-Infinity%
|
Fennec Pharmaceuticals Inc.
|
19.99 Million USD
|
-107.002%
|
Lipocine Inc.
|
-2.85 Million USD
|
1551.724%
|
Lexeo Therapeutics, Inc. Common Stock
|
-1.84 Million USD
|
2345.578%
|
Nautilus Biotechnology, Inc.
|
-5.7 Million USD
|
825.434%
|
SAB Biotherapeutics, Inc.
|
-1.5 Million USD
|
2847.543%
|
G1 Therapeutics, Inc.
|
75.31 Million USD
|
45.05%
|
Bellerophon Therapeutics, Inc.
|
-65 Thousand USD
|
63770.769%
|
Sage Therapeutics, Inc.
|
84.29 Million USD
|
50.904%
|
Ocugen, Inc.
|
-33.53 Million USD
|
223.404%
|
Mind Medicine (MindMed) Inc.
|
-3.16 Million USD
|
1408.855%
|
Q32 Bio Inc.
|
578 Thousand USD
|
-7060.208%
|
Brainstorm Cell Therapeutics Inc.
|
-265 Thousand USD
|
15717.358%
|
Alumis Inc. Common Stock
|
-1.28 Million USD
|
3323.209%
|
Equillium, Inc.
|
35.95 Million USD
|
-15.095%
|
Kyverna Therapeutics, Inc.
|
-1.7 Million USD
|
2524.487%
|
Coya Therapeutics, Inc.
|
500.67 Thousand USD
|
-8165.975%
|
CNS Pharmaceuticals, Inc.
|
-4134.00 USD
|
1001212.724%
|
Dominari Holdings Inc.
|
2.03 Million USD
|
-1929.72%
|
Edesa Biotech, Inc.
|
-183.47 Thousand USD
|
22657.243%
|
vTv Therapeutics Inc.
|
-13.59 Million USD
|
404.421%
|
Bio-Techne Corporation
|
773.07 Million USD
|
94.647%
|
Agios Pharmaceuticals, Inc.
|
17.31 Million USD
|
-138.963%
|
Harmony Biosciences Holdings, Inc.
|
460.78 Million USD
|
91.018%
|
Prelude Therapeutics Incorporated
|
-1.16 Million USD
|
3640.291%
|
Candel Therapeutics, Inc.
|
-23.98 Million USD
|
272.585%
|
iTeos Therapeutics, Inc.
|
11.69 Million USD
|
-253.817%
|
Nkarta, Inc.
|
-5.86 Million USD
|
805.163%
|
BioCardia, Inc.
|
-7.24 Million USD
|
670.92%
|
Iterum Therapeutics plc
|
-1.75 Million USD
|
2464.914%
|